ArticleEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences2025

Exploiting a type III interferon response to improve chemotherapeutic safety and efficacy.

Scott G Tilden et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.